STAT April 7, 2023
Eric Boodman

In a case that could reshape pregnancy in America, a federal judge on Friday sided with anti-abortion groups seeking a nationwide ban on abortion pills, ruling that the Food and Drug Administration acted improperly in approving mifepristone in 2000. The ruling will go into effect in seven days if a stay is not granted by an appeals court or by the Supreme Court.

The ruling, which is widely expected to be appealed, could affect people in every state, including those where abortion access is protected.

In issuing his decision, federal judge Matthew Kacsmaryk said that he did not “second-guess FDA’s decision-making lightly,” but said that the FDA “acquiesced on its legitimate safety concerns” due to political pressure at the time...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, FDA, Govt Agencies, Patient / Consumer, Provider
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article